These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 13429949)
1. [New observations regarding the use of BZ 55 in the treatment of diabetes]. Baquet R Maroc Med; 1957 Mar; 36(382):271-3. PubMed ID: 13429949 [No Abstract] [Full Text] [Related]
2. Oral treatment of diabetes mellitus with the sulfonamide BZ-55. HERNBERG CA Acta Endocrinol (Copenh); 1956 Nov; 23(3):281-8. PubMed ID: 13381391 [No Abstract] [Full Text] [Related]
3. New experimental and clinical results with BZ-55 (carbutamide) in Germany. ACHELIS JD Diabetes; 1957; 6(1):40-1; discussion, 43-5. PubMed ID: 13397420 [No Abstract] [Full Text] [Related]
4. [Use of BZ 55]. BAQUET R Maroc Med; 1956 Jul; 35(374):731-3. PubMed ID: 13368691 [No Abstract] [Full Text] [Related]
5. Clinical and pharmacological effects of substance BZ-55 in diabetes; (p-aminophenylsulfonyl butylcarbamide). ANDERSON RC; KIRTLEY WR; RIDOLFO AS; ROOT MA Diabetes; 1956; 5(5):351-7. PubMed ID: 13365474 [No Abstract] [Full Text] [Related]
6. [Mechanism of action of BZ 55 in human diabetes]. BASTENIE PA; CONARD V; DE MEUTTER R; FRANCKSON JR Bull Mem Soc Med Hop Paris; 1956; 72(26):799-806. PubMed ID: 13383374 [No Abstract] [Full Text] [Related]
11. The treatment of diabetic patients with the sulphonamide BZ-55. LINEHAN WD; NASH J J Ir Med Assoc; 1956 Oct; 39(232):109-11. PubMed ID: 13367546 [No Abstract] [Full Text] [Related]
12. Sudden death in a diabetic subject during treatment with BZ-55 (carbutamide). FEDERMAN DD; FIELD JB Diabetes; 1957; 6(1):67-70; discussion, 85-90. PubMed ID: 13397429 [No Abstract] [Full Text] [Related]
13. [Management of diabetes with a peroral sulfonamide derivative, BZ 55; preliminary experience]. AARSETH S Tidsskr Nor Laegeforen; 1956 Sep; 76(18):641-6. PubMed ID: 13380825 [No Abstract] [Full Text] [Related]
14. [The antidiabetic action of BZ 55 in clinical experience]. BELTRAMETTI L; ZAMPORI O G Clin Med; 1956 Sep; 37(9):1249-64. PubMed ID: 13384741 [No Abstract] [Full Text] [Related]
15. [Experiences on 1,000 diabetics treated with sulfonylureas (BZ 55 and D 860)]. BERTRAM F Gaz Med Fr; 1957 Mar; 64(6):519-24. PubMed ID: 13427958 [No Abstract] [Full Text] [Related]
16. [The effect of a hypoglycemic sulfonamide derivative (BZ 55) on the effectiveness of insulin in diabetics]. BARTELHEIMER H; MARING H Klin Wochenschr; 1956 Oct; 34(37-38):1011-6. PubMed ID: 13377627 [No Abstract] [Full Text] [Related]
17. [Treatment of ten cases of diabetes with oral hypoglycemic sulfonamide BZ 55 or nadisan]. FERNANDEZ BASABE E; GALAN J; OLIVER A; OLIVER-PASCUAL E; PURAS E Rev Esp Enferm Apar Dig Nutr; 1956; 15(2):478-88. PubMed ID: 13370980 [No Abstract] [Full Text] [Related]
18. [BZ 55 of D 860 as oral antidiabetic]. MEHNERT B; MEHNERT H Munch Med Wochenschr; 1956 Sep; 98(39):1325-8. PubMed ID: 13378442 [No Abstract] [Full Text] [Related]
19. [Clinical experiences with peroral administration of antidiabetic drug BZ-55 (invenol)]. BRESGEN C Med Klin; 1956 Jul; 51(29):1224-7. PubMed ID: 13358484 [No Abstract] [Full Text] [Related]
20. [Severe hypoglycemic reactions during peroral treatment of diabetes with N1-sulfanilyl-n-2-n-butylcarbamid (BZ 55)]. BENDFELDT E; OTTO H Munch Med Wochenschr; 1956 Aug; 98(35):1136-7. PubMed ID: 13369451 [No Abstract] [Full Text] [Related] [Next] [New Search]